Abstract
Purpose
Retinal nerve fiber layer (RNFL) thinning occurs in Parkinson’s disease (PD) and other neurodegenerative diseases. Idiopathic RBD (iRBD) is a well-established prodromal hallmark of synucleinopathies and occurs secondary to many neurodegenerative diseases, including PD. The aim of this study is to determine whether or not retinal structures are altered with the onset of rapid eye movement (REM) sleep behavior disorders (RBD).
Methods
In all, a total of 63 patients with PD, 14 patients with idiopathic RBD, and 26 sex- and age-matched healthy controls were enrolled and underwent optical coherence tomography measurements (HD-OCT (Zeiss) ) for the average and every quadrant of RNFL thickness. The REM Sleep Behavior Disorder Screening Questionnaire (RBDSQ) was used to classify PD patients with clinically probable RBD (PD + pRBD) or without probable RBD (PD − pRBD). Patients with iRBD were identified by polysomnography.
Results
For patients with RBD (idiopathic or secondary to PD), we found a significant decrease in RNFL thickness compared with groups without RBD (PD − pRBD and healthy controls) (all p < 0.05). Average RNFL thickness in patients with iRBD is significantly thinner than in healthy controls (p < 0.05). In PD, the average RNFL thickness was dramatically thinner in the PD + pRBD group than the PD − pRBD group (p < 0.005). Compared with healthy controls, RNFL thickness was slightly thinner in the drug-naive PD group but not the PD group with drug treatment. Multiple linear regression analysis showed that RBDSQ score was negatively associated with average and inferior RNFL variation in PD (all p < 0.005).
Conclusions
The findings show that RNFL was slightly but significantly thinner in idiopathic RBD. In PD, RNFL thickness may vary depending on the presence of RBD.
Similar content being viewed by others
Abbreviations
- PD + pRBD:
-
PD patients with clinical probable RBD
- PD − pRBD:
-
PD patients without probable RBD
- RNFL:
-
Retinal nerve fiber layer
- PDND:
-
newly diagnosed PD patients with drug-naive
- PDED:
-
PD patients exposure to drug treatment
References
Boeve BF, Silber MH, Saper CB, Ferman TJ, Dickson DW, Parisi JE, et al. (2007) Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain 130:2770–2788
Boeve BF, Silber MH, Ferman TJ, Lucas JA, Parisi JE (2001) Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy. Mov Disord 16:622–630
Chiu HF, Wing YK, Lam LC, Li SW, Lum CM, Leung T, et al. (2000) Sleep-related injury in the elderly—an epidemiological study in Hong Kong. Sleep 23:513–517
Schenck CH, Boeve BF, Mahowald MW (2013) Delayed emergence of a parkinsonian disorder dementia in 81 % of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: a 16-year update on a previously reported series. Sleep Med 14:744–748
Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M (1997) Alpha-synuclein in Lewy bodies. Nature 388:839–840
Neikrug AB, Avanzino JA, Liu L, Maglione JE, Natarajan L, Corey-Bloom J, et al. (2014) Parkinson’s disease and REM sleep behavior disorder result in increased non-motor symptoms. Sleep Med 15:959–966
Hu Y, Yu SY, Zuo LJ, Cao CJ, Wang F, Chen ZJ, et al. (2015) Parkinson disease with REM sleep behavior disorder: features, α-synuclein, and inflammation. Neurology 84:888–894
Joutsa J, Gardberg M, Röyttä M, Kaasinen V (2014) Diagnostic accuracy of parkinsonism syndromes by general neurologists. Parkinsonism Relat Disord 20:840–844
Theelen T (2014) Photoreceptor layer thinning is not specific for Parkinson’s disease. Mov Disord 29:1331–1332
Jiménez B, Ascaso FJ, Cristóbal JA, López DVJ (2014) Development of a prediction formula of Parkinson disease severity by optical coherence tomography. Mov Disord 29:68–74
Lee JY, Ahn J, Kim TW, Jeon BS (2014) Optical coherence tomography in Parkinson’s disease: is the retina a biomarker. J Parkinsons Dis 4:197–204
Yu JG, Feng YF, Xiang Y, Huang JH, Savini G, Parisi V, et al. (2014) Retinal nerve fiber layer thickness changes in Parkinson disease: a meta-analysis. PLoS One 9:e85718
Kramer SG, Potts AM, Mangnall Y (1971) Dopamine: a retinal neurotransmitter. II. Autoradiographic localization of H3-dopamine in the retina. Investig Ophthalmol 10:617–624
Harnois C, Di PT (1990) Decreased dopamine in the retinas of patients with Parkinson’s disease. Invest Ophthalmol Vis Sci 31:2473–2475
Beach TG, Carew J, Serrano G, Adler CH, Shill HA, Sue LI, et al. (2014) Phosphorylated α-synuclein-immunoreactive retinal neuronal elements in Parkinson’s disease subjects. Neurosci Lett 571:34–38
Inzelberg R, Ramirez JA, Nisipeanu P, Ophir A (2004) Retinal nerve fiber layer thinning in Parkinson disease. Vis Res 44:2793–2797
Moreno-Ramos T, Benito-León J, Villarejo A, Bermejo-Pareja F (2013) Retinal nerve fiber layer thinning in dementia associated with Parkinson’s disease, dementia with Lewy bodies, and Alzheimer’s disease. J Alzheimers Dis 34:659–664
Satue M, Garcia-Martin E, Fuertes I, Otin S, Alarcia R, Herrero R, et al. (2013) Use of Fourier-domain OCT to detect retinal nerve fiber layer degeneration in Parkinson’s disease patients. Eye (Lond) 27:507–514
Nomura T, Inoue Y, Kagimura T, Uemura Y, Nakashima K (2011) Utility of the REM sleep behavior disorder screening questionnaire (RBDSQ) in Parkinson’s disease patients. Sleep Med 12:711–713
Poryazova R, Oberholzer M, Baumann CR, Bassetti CL (2013) REM sleep behavior disorder in Parkinson’s disease: a questionnaire-based survey. J Clin Sleep Med 9:55–59A
Montplaisir J, Gagnon JF, Fantini ML, Postuma RB, Dauvilliers Y, Desautels A, et al. (2010) Polysomnographic diagnosis of idiopathic REM sleep behavior disorder. Mov Disord 25:2044–2051
American Academy of Sleep Medicine (2007) The AASM manual for the scoring of sleep and associated events—rules, terminology and technical specifications. American Academy of Sleep Medicine, Westchester, IL
Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17:427–442
Postuma RB, Gagnon JF, Montplaisir J (2013) Rapid eye movement sleep behavior disorder as a biomarker for neurodegeneration: the past 10 years. Sleep Med 14:763–767
Postuma RB, Iranzo A, Hogl B, Arnulf I, Ferini-Strambi L, Manni R, et al. (2015) Risk factors for neurodegeneration in idiopathic rapid eye movement sleep behavior disorder: a multicenter study. Ann Neurol 77:830–839
Djamgoz MB, Hankins MW, Hirano J, Archer SN (1997) Neurobiology of retinal dopamine in relation to degenerative states of the tissue. Vis Res 37:3509–3529
Spund B, Ding Y, Liu T, Selesnick I, Glazman S, Shrier EM, et al. (2013) Remodeling of the fovea in Parkinson disease. J Neural Transm 120:745–753
Sen A, Tugcu B, Coskun C, Ekinci C, Nacaroglu SA (2014) Effects of levodopa on retina in Parkinson disease. Eur J Ophthalmol 24:114–119
Tosini G, Menaker M (1996) Circadian rhythms in cultured mammalian retina. Science 272:419–421
Schmoll C, Lascaratos G, Dhillon B, Skene D, Riha RL (2011) The role of retinal regulation of sleep in health and disease. Sleep Med Rev 15:107–113
Musiek ES (2015) Circadian clock disruption in neurodegenerative diseases: cause and effect. Front Pharmacol 6:29
Braak H, Del TK, Bratzke H, Hamm-Clement J, Sandmann-Keil D, Rüb U (2002) Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson’s disease (preclinical and clinical stages). J Neurol 249(Suppl 3):III/1–5
Acknowledgments
Chun-feng Liu, Zi-jiao Yang, Cheng-jie Mao conceived and designed the experiments. Zi-jiao Yang, Jing Wei, and Xiao-yan Ji performed the experiments. All authors analyzed the data, discussed the results and co-wrote and commented on the manuscript. All authors have approved the final article.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Financial disclosures
All funding sources and potential conflicts of interest from each author that relate to the research were covered in the article.
Funding sources for study
This work was supported by the Jiangsu Provincial Special Program of Medical Science (BL2014042); Suzhou Clinical Key Disease Diagnosis and Treatment Technology Foundation (LCZX201304); and Suzhou Clinical Research Center of Neurological Disease (Szzx201503). This was also partly supported by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Electronic supplementary material
Supplementary Table 1
(DOCX 38 kb)
Rights and permissions
About this article
Cite this article
Yang, Zj., Wei, J., Mao, Cj. et al. Retinal nerve fiber layer thinning: a window into rapid eye movement sleep behavior disorders in Parkinson’s disease. Sleep Breath 20, 1285–1292 (2016). https://doi.org/10.1007/s11325-016-1366-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11325-016-1366-4